ARKRAY USA Recognized by Governor of New Jersey for Assistance During COVID-19 Pandemic
ARKRAY USA Launches Phazix Pill Swallowing Gel--Unique Gel for People with Problems Swallowing Tablets, Capsules and Powders--
MINNEAPOLIS, August 26th, 2019 (PR NEWSWIRE) – ARKRAY USA, Inc. announced today the US launch of Phazix, the first and only over-the-counter pill swallowing gel available in the US market. Phazix is all natural and is designed to help people who have difficulty swallowing tablets, capsules and powders. Trouble swallowing medication is experienced by an estimated 18 million adults including the elderly and those with disabilities or neurological conditions.1 Additionally, 50% of parents have a child who is unable to swallow a standard-size pill.2
ARKRAY USA Launches Assure® Slide Swallowing Aid --Unique and Simple Solution for People with Swallowing Difficulties--
MINNEAPOLIS, January 21, 2019 (PR NEWSWIRE) – ARKRAY USA, Inc. announced today the US commercial launch into the post-acute care market of Assure® Slide, a swallowing aid for people who have difficulty swallowing tablets or capsules. Assure Slide is designed to address the needs of the estimated 15-33% of long-term care residents who have some level of swallowing difficulties.1
ARKRAY USA Changes Name of Long-Term Care Division to Professional Healthcare Division
MINNEAPOLIS, December 10, 2018 (PR NEWSWIRE) – ARKRAY USA, Inc., a leader in diabetes care products, announced today that the Company’s Long-term Care Division will be renamed the Professional Healthcare Division.
ARKRAY USA Launches Two New Blood Glucose Monitoring Systems in the United States
MINNEAPOLIS, November 26, 2018 (PR NEWSWIRE) – ARKRAY USA, Inc., a leader in diabetes care products, announced today the US launch of the GLUCOCARD® Shine Connex Bluetooth® enabled and the GLUCOCARD® Shine Express audio-enabled blood glucose monitoring systems (BGMS). ARKRAY’s GLUCOCARD Shine family of BGMS now consists of four distinct meters that use the same test strip platform.
ARKRAY USA Launches Safety Pen Needles
MINNEAPOLIS, August 1, 2018 (PR NEWSWIRE) – ARKRAY USA, Inc., a leader in diabetes care products, announced today the US launch of the Assure® ID Safety Pen Needles. Safety pen needles are designed to protect healthcare professionals and their patients from unintended needlesticks during the injection of insulin.
ARKRAY USA Nominated as Finalist for Walmart Supplier Award - Finalist in the Accelerate the Multi-Channel Category
MINNEAPOLIS, February 20, 2018 (PR NEWSWIRE) – ARKRAY USA, Inc., a leader in diabetes care products, announced today the Company was recognized at the recent Walmart Supplier Growth Summit as a finalist for a Supplier Award in the “Accelerate the Multi-Channel” category.
ARKRAY USA manufactures and supports the ReliOn™ brand of blood glucose monitoring systems (BGMS), which are available only at Walmart.
ARKRAY USA AND MELLITUS HEALTH ANNOUNCE LICENSING AGREEMENT
Diabetes Healthcare Leader Licenses Comprehensive Insulin Titration Software for Clinicians
ARKRAY USA Announces the Availability of the GLUCOCARD® Shine XL Blood Glucose Monitoring System Provides Highly Accurate Readings and is Easy to Use
MINNEAPOLIS, November 10, 2017 (PR NEWSWIRE) – ARKRAY USA, Inc., a leader in diabetes care products, announced today that the GLUCOCARD® Shine XL, ARKRAY’s newest blood glucose monitoring system (BGMS), is now being shipped to customers in the United States.
New Blood Glucose Monitoring System Launched by ARKRAY USA - GLUCOCARD® Shine XL Provides Highly Accurate Readings and is Easy to Use
MINNEAPOLIS, August 8, 2017 (PR NEWSWIRE) – ARKRAY USA, Inc., a leader in diabetes care products, announced today the launch of the GLUCOCARD Shine XL blood glucose monitoring system (BGMS). Highly accurate with a large LED screen, the GLUCOCARD Shine XL BGMS offers an ergonomic designed meter to provide a secure grip during testing. The large screen is intended to facilitate quick and easy viewing of blood glucose test results.